Literature DB >> 22252783

Transcriptional regulation of the GLAST/EAAT-1 gene in rat and man.

Tina Unger1, Nicole Lakowa, Stefanie Bette, Jürgen Engele.   

Abstract

Various acute and chronic brain diseases result in disturbed expression of the glial glutamate transporters, GLAST/EAAT-1 and GLT-1/EAAT-2, and subsequent secondary neuronal cell death. The idea that glutamate-induced brain damage can be prevented by restoring glutamate homeostasis in the injured brain, focussed previous efforts on identifying the network controlling astrocytic glutamate transport. Since most of this work was performed with rat astrocytes, we now sought to compare the transcriptional regulation of the GLAST/EAAT-1 gene in rat and man. Reporter gene assay demonstrated that the human GLAST/EAAT-1 promoter comprises the 2.3 kb region immediately flanking the 5'-end of the human GLAST/EAAT-1 gene. Cloning of the previously unknown promoter of rat GLAST/EAAT-1 gene demonstrated maximal reporter gene activity with a sequence comprising the 1.5 kb region flanking the 5'-end of the gene as well as non-coding exon 1, and intron 1-2. Although the promoter regions from both species lacked sequence homology, they contained numerous identical consensus motifs. In human promoter constructs, dbcAMP, PACAP, EGF, and TGFα, which represent potent stimulators of endogenous GLAST/EAAT-1 expression, only further increased reporter gene activity in the presence of the GLAST/EAAT-1 3'-UTR. By contrast, the rat GLAST/EAAT-1 3'-UTR only mediated the stimulatory increases of dbcAMP. Moreover, the GLAST/EAAT-1 3'-UTR repressed constitutive GLAST/EAAT-1 expression in man, but enhanced GLAST/EAAT-1 transcription in rat. Together, our findings suggest the existence of close functional similarities of the GLAST/EAAT-1 promoter regions in man and rat and further point to a species-specific function of the GLAST/EAAT-1 3'-UTR in constitutive and regulated GLAST/EAAT-1 expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252783     DOI: 10.1007/s10571-011-9790-2

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  34 in total

Review 1.  Determinants of regional and local diversity within the astroglial lineage of the normal central nervous system.

Authors:  James A Hewett
Journal:  J Neurochem       Date:  2009-07-17       Impact factor: 5.372

2.  Disturbed neurotransmitter transporter expression in Alzheimer's disease brain.

Authors:  Kevin H Chen; Edmund A Reese; Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

4.  Changes in glutamate transporter expression in mouse forebrain areas following focal ischemia.

Authors:  Pirusha Ketheeswaranathan; Neil A Turner; Emma J Spary; Trevor F C Batten; Barry W McColl; Sikha Saha
Journal:  Brain Res       Date:  2011-08-19       Impact factor: 3.252

5.  Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors:  J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

6.  Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.

Authors:  Marc A Thomas; Darren M Preece; Jacqueline M Bentel
Journal:  Biochem J       Date:  2010-01-15       Impact factor: 3.857

7.  Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.

Authors:  P F Behrens; P Franz; B Woodman; K S Lindenberg; G B Landwehrmeyer
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

8.  Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.

Authors:  Tom Walsh; Jon M McClellan; Shane E McCarthy; Anjené M Addington; Sarah B Pierce; Greg M Cooper; Alex S Nord; Mary Kusenda; Dheeraj Malhotra; Abhishek Bhandari; Sunday M Stray; Caitlin F Rippey; Patricia Roccanova; Vlad Makarov; B Lakshmi; Robert L Findling; Linmarie Sikich; Thomas Stromberg; Barry Merriman; Nitin Gogtay; Philip Butler; Kristen Eckstrand; Laila Noory; Peter Gochman; Robert Long; Zugen Chen; Sean Davis; Carl Baker; Evan E Eichler; Paul S Meltzer; Stanley F Nelson; Andrew B Singleton; Ming K Lee; Judith L Rapoport; Mary-Claire King; Jonathan Sebat
Journal:  Science       Date:  2008-03-27       Impact factor: 47.728

9.  Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist.

Authors:  Rose-Marie Karlsson; Kohichi Tanaka; Markus Heilig; Andrew Holmes
Journal:  Biol Psychiatry       Date:  2008-06-12       Impact factor: 13.382

Review 10.  Long-range control of gene expression: emerging mechanisms and disruption in disease.

Authors:  Dirk A Kleinjan; Veronica van Heyningen
Journal:  Am J Hum Genet       Date:  2004-11-17       Impact factor: 11.025

View more
  10 in total

Review 1.  GLAST But Not Least--Distribution, Function, Genetics and Epigenetics of L-Glutamate Transport in Brain--Focus on GLAST/EAAT1.

Authors:  Omar Šerý; Nilufa Sultana; Mohammed Abul Kashem; David V Pow; Vladimir J Balcar
Journal:  Neurochem Res       Date:  2015-05-14       Impact factor: 3.996

Review 2.  The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.

Authors:  Edward Pajarillo; Asha Rizor; Jayden Lee; Michael Aschner; Eunsook Lee
Journal:  Neuropharmacology       Date:  2019-03-06       Impact factor: 5.250

3.  Transcriptional Regulation of the Astrocytic Excitatory Amino Acid Transporter 1 (EAAT1) via NF-κB and Yin Yang 1 (YY1).

Authors:  Pratap Karki; Clifford Kim; Keisha Smith; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  J Biol Chem       Date:  2015-08-12       Impact factor: 5.157

Review 4.  SLC1 glutamate transporters.

Authors:  Christof Grewer; Armanda Gameiro; Thomas Rauen
Journal:  Pflugers Arch       Date:  2013-11-19       Impact factor: 3.657

5.  Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma.

Authors:  M Yanagisawa; T Aida; T Takeda; K Namekata; T Harada; R Shinagawa; K Tanaka
Journal:  Cell Death Dis       Date:  2015-03-19       Impact factor: 8.469

Review 6.  Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse.

Authors:  Sade Spencer; Peter W Kalivas
Journal:  Int J Neuropsychopharmacol       Date:  2017-10-01       Impact factor: 5.176

7.  Upregulation of GLT-1 via PI3K/Akt Pathway Contributes to Neuroprotection Induced by Dexmedetomidine.

Authors:  Mengyuan Peng; Xiaomin Ling; Ruixue Song; Xuan Gao; Zhifeng Liang; Fang Fang; Jing Cang
Journal:  Front Neurol       Date:  2019-09-27       Impact factor: 4.003

Review 8.  Epigenetic Regulation of Excitatory Amino Acid Transporter 2 in Neurological Disorders.

Authors:  Mohammad Afaque Alam; Prasun K Datta
Journal:  Front Pharmacol       Date:  2019-12-13       Impact factor: 5.810

9.  EAAT1-dependent slc1a3 Transcriptional Control depends on the Substrate Translocation Process.

Authors:  Dinorah Hernández-Melchor; Leticia Ramírez-Martínez; Luis Cid; Cecilia Palafox-Gómez; Esther López-Bayghen; Arturo Ortega
Journal:  ASN Neuro       Date:  2022 Jan-Dec       Impact factor: 5.200

10.  The expression and function of glutamate aspartate transporters in Bergmann glia are decreased in neuronal nitric oxide synthase-knockout mice during postnatal development.

Authors:  Vasiliki Tellios; Matthew J E Maksoud; Wei-Yang Lu
Journal:  Glia       Date:  2022-01-10       Impact factor: 8.073

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.